Sign in
4

Changes in Ownership

Aprea Therapeutics, Inc. Filed Acc 0001140361-21-006732

SVP, Chief Scientific Officer acquired 19,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Abrahmsen Lars B. SVP, Chief Scientific Officer 2021-02-25 Grant or award +19,000 19,000 D
Derivatives
Abrahmsen Lars B. SVP, Chief Scientific Officer 2021-02-25 Grant or award · Stock Option (right to Buy) +82,000 82,000 D
Loading xslF345X03/form4.xml…